- Associated Press•7 days ago
On a per-share basis, the Holon, Israel-based company said it had a loss of 17 cents. The drug developer posted revenue of $53,000 in the period. For the year, the company reported that its loss widened ...
- PR Newswire•7 days ago
HOLON, Israel, Feb. 15, 2017 /PRNewswire/ -- Compugen Ltd. (NASDAQ: CGEN), a leading predictive drug discovery company, today reported financial results for the fourth quarter and year ended December 31, ...
- PR Newswire•23 days agoCompugen Fourth Quarter and Yearend 2016 Conference Call Scheduled for Wednesday, February 15, 2017 at 10:00 AM EST
HOLON, Israel, January 30, 2017 /PRNewswire/ -- Compugen Ltd. (NASDAQ: CGEN ), a leading predictive drug discovery company, today announced that the Company will host a conference call on Wednesday, February ...
CGEN : Summary for Compugen Ltd. - Yahoo Finance
Compugen Ltd. (CGEN)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
|Bid||4.10 x 4700|
|Ask||5.65 x 800|
|Day's Range||4.50 - 4.60|
|52 Week Range||4.40 - 7.57|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-9.83|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|